Study of a new drug for advanced solid tumors
Part of Cancer clinical trials.
This study tests an investigational drug called RT036 for people with advanced solid tumors. The goal is to find a safe dose and see if it helps shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have an advanced solid tumor cancer that has been confirmed by biopsy or other tests.
- You are generally able to care for yourself (up and about, not bedridden).
- You have at least one tumor that can be measured on a scan (unless you are in the dose-escalation part).
- If your cancer has spread to the brain, it must have been treated and stable, with no current need for steroids.
- You must not have certain serious lung conditions or poorly controlled high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called RT023 in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find out if RT023 is safe and effective, and what dose is best.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This trial tests a combination of two investigational drugs, MHB036C and MHB039A, in people with advanced breast cancer or other solid tumors that have spread. The goal is to see if this combination can shrink tumors and help patients live longer.
This trial tests an experimental drug for people with advanced solid tumors, including small cell lung cancer, that have stopped responding to standard treatments. The goal is to find out if the drug is safe and effective.
This trial tests a new drug called PTT-4256 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find the best dose and see if it helps shrink or control the cancer.
This trial tests a new drug called MHB042C for people with advanced solid tumors that have stopped responding to other treatments. It aims to see if the drug is safe and effective.
Hear when a new Advanced Malignant Solid Tumours trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.